More Simcere Pharmaceutical Group Limited news
Simcere Pharmaceutical Group LimitedHKEX: 2096

Next Day Disclosure Return

Nov 17, 2026 at 4:29 AM EST · Issued by Simcere Pharmaceutical Group Limited via HKEXnews

Filed with HKEX · Stock code 2096 · Nov 17, 2026 at 4:29 AM EST · 8 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-2891

Simcere Pharmaceutical Group Limited on 6ix

Earlier from Simcere Pharmaceutical

  • Voluntary announcement - the clinical trial approval for SIM0712 (STAT6) issued by the national medical products administrationNov 16
  • Voluntary announcement - inclusion of Sanbexin sublingual tablets into the new national reimbursement drug listNov 15
  • Voluntary announcement - the clinical trial approval for SIM0725 (CD122) issued by the national medical products administrationNov 10
  • Voluntary announcement - the clinical trial approval for SIM0709 (TL1A/il-23P19 bispecific antibody) issued by the german regulatory authority and ethics committeeNov 9
  • Voluntary announcement - new drug application (nda) of zemprocitinib for the treatment of rheumatoid arthritis was accepted by the national medical products administrationNov 5
All Simcere Pharmaceutical news releases↗

Follow Simcere Pharmaceutical into a list and get an email when it puts out news.

Follow Simcere Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer